Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teladoc Health, Inc. Common Stock (NY:TDOC)

8.140 -0.490 (-5.68%)
Official Closing Price Updated: 6:30 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teladoc Health, Inc. Common Stock

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
53 54 Next >
2 Beaten-Down Stocks to Buy in 2023 and Hold for at Least 5 Years
Etsy and Teladoc are two growth stocks that still have plenty of long-term viability. 
Via The Motley Fool
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
2 Top Stocks to Buy Without Hesitation in 2023
Looking beyond the bear market-driven share price drop is key. 
Via The Motley Fool
2 Explosive Growth Stocks to Buy in 2023
Growth stocks aren't thrilling investors like they did in 2020, but hope may be on the horizon. 
Via The Motley Fool
Nasdaq Bear Market: 5 Special Growth Stocks You'll Regret Not Buying on the Dip
A 33% plunge in the Nasdaq Composite is the perfect time to go shopping for game-changing businesses trading at a discount. 
Via The Motley Fool
Teladoc Stock: Buy, Sell, or Hold in 2023?
This high-growth stock is making all the right moves. 
Via The Motley Fool
Where Teladoc Health Stands With Analysts
 
Via Benzinga
Why Teladoc Health Stock Was Sliding Today
Shares of the telehealth provider fell after management announced layoffs. 
Via The Motley Fool
3 Disruptors I Love Right Now
Disruptive companies have been among the most beaten-down, but could provide the best upside moving forward. 
Via The Motley Fool
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
Can gains in Tesla, Zoom, Exact Sciences, and other growth stocks set the stage for Cathie Woods' Ark Innovation Fund to stage a comeback in 2023? 
Via MarketBeat
Topics ETFs
Meta Platforms, Pinterest, W.W. Grainger And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mixed, with the Nasdaq Composite gaining over 300 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Teladoc Health to Announce Fourth Quarter 2022 Financial Results
From Teladoc Health, Inc.
Via GlobeNewswire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The iconic money manager with a penchant for aggressive growth aims to close out January with a bang. 
Via The Motley Fool
Another Chance to Look Back and Score Stock Picks
"I think it's helpful to score because if you don't score, you're not really sure if you're doing it right." -- Motley Fool co-founder David Gardner 
Via The Motley Fool
2 Top Stocks to Buy In a 2023 Bear Market
Even if market volatility continues, investors don't have to run for the hills. 
Via The Motley Fool
2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
Two of these stocks have what it takes to rebound and deliver lasting gains. 
Via The Motley Fool
Why Teladoc Stock Popped 5% Today
Cathie Wood keeps buying shares of the telemedicine company. Should you? 
Via The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The growth-focused money manager is making moves. 
Via The Motley Fool
3 Growth Stocks That Are Too Cheap to Ignore
When a market rebound finally occurs, the share prices of Teladoc, Airbnb, and Fiverr should rebound as well. 
Via The Motley Fool
1 Excellent Growth Stock to Buy Near Its 52-Week Low
This year can't be much worse than 2022 for this healthcare specialist. 
Via The Motley Fool
Is Amazon the Future of Healthcare?
The e-commerce titan announced the RxPass subscription for Prime members. What companies will this service disrupt, and can Amazon stock benefit? 
Via The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The growth-focused money manager is making moves. 
Via The Motley Fool
Did Teladoc Just Take a Big Step Towards Profitability?
Teladoc is winning when it comes to revenue and membership growth -- but profit has been elusive. 
Via The Motley Fool
Teladoc Health Releases Annual Corporate Social Responsibility Report
Industry leader details new commitments to drive health equity, reports 33% increase in employee volunteerism 
From Teladoc Health, Inc.
Via GlobeNewswire
Want to Start 2023 Out Right? Buy These Bargain Growth Stocks
These stocks could boost your portfolio over time. 
Via The Motley Fool
Why Teladoc Health Stock Fell Again on Thursday
The company continues to make investors and pundits more bearish with its latest announcement. 
Via The Motley Fool
2 Former Pandemic Darlings Poised To Lead Again
As time passes, some of the pandemic darlings will go the way of CMGI and Pets.com after the dot com bubble, while others will rise again to lead the market. So, which two former pandemic darlings may... 
Via Talk Markets
Why Is NeuroSense (NRSN) Stock Up 98% Today?
NeuroSense (NRSN) stock is taking off on Thursday as investors react to data from a biomarker study concerning Alzheimer's disease (AD). 
Via InvestorPlace
Teladoc Layoffs 2023: What to Know About the Latest TDOC Job Cuts
Teladoc is trimming its workforce in order to cut costs, but today's TDOC stock traders aren't too pleased with this development. 
Via InvestorPlace
Teladoc Health Slashes 300 Redundant Non-Clinician Roles, Reduces Office Spaces To Save Costs
Teladoc Health, Inc (NYSE: TDOC) slashed 6% of its workforce and underwent other initiatives during the fourth quarter of 2022 to reduce operating costs. 
Via Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
53 54 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.